在制药行业，一批创新型企业正利用一种中国独有的优势 — — 数量巨大且低成本的技术人才 — — 来推动药物研究，并通过研发品牌药物来进入更高利润的经营模式。
In the pharmaceutical industry, for example, a crop of innovative companies is developing a distinctively Chinese approach to drug discovery: massive scale and low-cost technical talent. These firms may be on their way to cracking the more lucrative business of brand-name drugs.